Purpose : To determine FSH concentration behavior before and after cetrorelix 0.25 mg administration in the GnRHantagonist multiple-dose protocol on day 6 of ovarian stimulation with 150-300 IU daily recombinant FSH. Methods : Blood samples for FSH measurements were drawn from seven women every 15 min from 8 h prior to the first cetrorelix administration in the GnRH-antagonist multiple-dose protocol until 15-32 h thereafter. Results : No significant change of FSH concentration was observed. Conclusions : This observation indicates that no rationale exists of increasing the daily FSH dosage concomitantly to the GnRH-antagonist administration to compensate for a drop of endogenous FSH.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.